BIOCON vs WOCKPHARMA: Stock Comparison

Biocon Limited vs Wockhardt Ltd

Live data: 22 July 2026, 3:00 PM IST • Source: NSE and company filings

Biocon Limited is the larger company by market capitalisation. Biocon Limited shows a higher dividend yield, while Wockhardt Ltd shows a lower P/E, a higher ROE and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Biocon Limited and Wockhardt Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, BIOCON is more favourable on 3 of 13 scored metrics and WOCKPHARMA on 9These counts are context-free and are not an overall rating.

Key Differences

Market Cap

BIOCON is the larger company

₹70,989 Cr vs ₹30,362 Cr

P/E Ratio

WOCKPHARMA has a lower P/E

144.46x vs 185.25x

P/B Ratio

BIOCON has a lower P/B

2.1x vs 6.23x

EPS

WOCKPHARMA has higher earnings per share

₹13.1 vs ₹2.86

Dividend Yield

BIOCON has a higher dividend yield

0.11% vs 0%

Revenue Growth (TTM YoY)

WOCKPHARMA has faster revenue growth

26% vs 2.3%

EPS Growth (TTM YoY)

WOCKPHARMA has faster EPS growth

0% vs -72.5%

Qtr Sales Growth

WOCKPHARMA has stronger quarterly sales growth

29.9% vs 2.25%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

Metric	BIOCON	WOCKPHARMA
Sector	Healthcare	Healthcare
Industry	Pharmaceuticals	Pharmaceuticals

Price

Metric	BIOCON	WOCKPHARMA
Live Price	₹437.25	₹1,867
Day Change	-0.69%	-1.55%
Volume	51.42 L	7.17 L
52-Week High	₹447.15	₹2,422.3
52-Week Low	₹331	₹1,086.7
Distance from 52W High	-2.21%	-22.92%

Valuation

Metric	BIOCON	WOCKPHARMA
Market Cap	₹70,989 Cr	₹30,362 Cr
P/E Ratio	185.25x	144.46x
P/B Ratio	2.1x	6.23x
EPS	₹2.86	₹13.1
Book Value	₹210.14	₹304
Dividend Yield	0.11%	0%

Growth

Metric	BIOCON	WOCKPHARMA
Revenue Growth (TTM YoY)	2.3%	26%
EPS Growth (TTM YoY)	-72.5%	0%
Qtr Sales Growth	2.25%	29.9%
Qtr Profit Growth	-62%	688%

Profitability & Leverage

Metric	BIOCON	WOCKPHARMA
ROE	1.4%	6.11%
ROCE	3.75%	7.55%
Net Margin	2.29%	3.3%
Operating Margin	20.4%	19.3%
Debt to Equity	0.45x	0.45x

Shareholding

As of Jun 2026 • change vs previous quarter

Metric	BIOCON	WOCKPHARMA
Promoter Holding	29.73%▼ 0.17 pp	49.08%
FII Holding	8.16%▲ 0.64 pp	7.09%▲ 0.1 pp
DII Holding	23.37%▼ 0.7 pp	10.96%▲ 0.41 pp
Public Holding	23.74%▲ 0.33 pp	32.83%▼ 0.52 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Biocon Limited and Wockhardt Ltd.

Related Comparisons

Infosys vs TCS HDFC Bank vs ICICI Bank Axis Bank vs Kotak Mahindra Bank HCL Technologies vs Wipro Hindustan Unilever vs ITC Maruti Suzuki vs Tata Motors

Browse all stock comparisons →

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.